Agilent | A - Current Assets


Agilent reported $4.69B in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Abbott USD 23.5B 1.02B Sep/2026
Agilent USD 4.69B 70M Jun/2026
Align Technology USD 2.73B 63.03M Sep/2026
Bio Techne USD 824.83M 80.43M Sep/2026
Bio-Rad Laboratories USD 3.08B 58.1M Sep/2026
Bruker USD 2.16B 67.9M Sep/2026
Charles River Laboratories USD 1.54B 5.92M Sep/2026
Danaher USD 14.79B 1.41B Sep/2026
Dentsply International USD 1.98B 50M Sep/2026
Edwards Lifesciences USD 7.25B 428.6M Sep/2026
Henry Schein USD 4.78B 176M Sep/2026
Illumina USD 3.04B 201M Sep/2026
Intuitive Surgical USD 10.65B 1.68B Sep/2026
IQVIA Holdings USD 6.45B 225M Sep/2026
Laboratory Of America USD 3.97B 151.3M Sep/2026
Mettler Toledo International USD 1.38B 28.79M Sep/2026
Myriad Genetics USD 289M 23.8M Jun/2026
OraSure Technologies USD 222.94M 17.84M Jun/2026
Quest Diagnostics USD 3.12B 273M Sep/2026
Quidel USD 1.45B 69.4M Sep/2026
Repligen USD 1.24B 41.43M Sep/2026
Revvity USD 1.86B 436.33M Sep/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
Thermo Fisher Scientific USD 25.62B 2.25B Sep/2026
Waters USD 3.9B 186M Jun/2026
Zimmer Biomet Holdings USD 5.13B 32.3M Sep/2026